Financial Enhancement Group’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-260
Closed -$25K 116
2022
Q3
$25K Hold
260
0.01% 155
2022
Q2
$28K Hold
260
0.01% 151
2022
Q1
$31K Hold
260
0.01% 150
2021
Q4
$37K Hold
260
0.01% 149
2021
Q3
$31K Hold
260
0.01% 155
2021
Q2
$30K Hold
260
0.01% 144
2021
Q1
$31K Hold
260
0.01% 137
2020
Q4
$28K Hold
260
0.01% 158
2020
Q3
$28K Hold
260
0.01% 142
2020
Q2
$24K Hold
260
0.01% 152
2020
Q1
$21K Hold
260
0.01% 165
2019
Q4
$23K Hold
260
0.01% 159
2019
Q3
$22K Hold
260
0.01% 160
2019
Q2
$22K Hold
260
0.01% 158
2019
Q1
$21K Hold
260
0.01% 176
2018
Q4
$19K Hold
260
0.01% 160
2018
Q3
$19K Hold
260
0.01% 160
2018
Q2
$16K Hold
260
0.01% 160
2018
Q1
$16K Buy
+260
New +$15.7K 0.01% 165

Other funds holding ABT

Financial Enhancement Group's ABT Position: Q4 2022 in Review

Financial Enhancement Group sold out of Abbott (ABT) in Q4 2022, closing a stake of 260 shares — an estimated $25K sold.

Financial Enhancement Group first reported a position in ABT in Q1 2018 and held it in 19 quarters. The position peaked at $37K in Q4 2021. 2,764 funds tracked by Wall St. Rank hold ABT as of Q4 2022.

  • Financial Enhancement Group reported no remaining Abbott position as of Q4 2022 after selling out during the quarter.
  • Financial Enhancement Group sold 260 Abbott shares in Q4 2022, an estimated $25K.
  • Financial Enhancement Group first reported a position in Abbott in Q1 2018 and held it in 19 quarters.
  • Financial Enhancement Group's Abbott position peaked at $37K in Q4 2021.
  • 2,764 funds tracked by Wall St. Rank held Abbott as of Q4 2022.

Based on Financial Enhancement Group's 13F filing for Q4 2022, filed 9 Feb 2023.